INCY - Incyte Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$130.07
DETAILS
HIGH:
$155.00
LOW:
$104.00
MEDIAN:
$130.00
CONSENSUS:
$130.07
UPSIDE:
4.26%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 719,545 | $81.6M | 0.2% | +42,875 | INCREASED |
| Dalio | 168,253 | $19.1M | 0.1% | +37,957 | INCREASED |
| Cooperman | 4,016 | $455,254 | 0.0% | +816 | INCREASED |
| Wood | 0 | $0 | -- | -3,100 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-22 | Gardner David H | officer: EVP, Chief Strategy Officer | F-InKind | 920 | $126.93 | $117K |
| 2026-09-15 | CAGNONI PABLO J | officer: President, Global Head of R&D | SELL | 9,233 | $120.50 | $1.1M |
| 2026-09-15 | CAGNONI PABLO J | officer: President, Global Head of R&D | SELL | 13,985 | $120.49 | $1.7M |
| 2026-09-15 | CAGNONI PABLO J | officer: President, Global Head of R&D | M-Exempt | 6,477 | $64.25 | $416K |
| 2026-09-15 | CAGNONI PABLO J | officer: President, Global Head of R&D | M-Exempt | 2,957 | $61.76 | $183K |
| 2026-09-15 | CAGNONI PABLO J | officer: President, Global Head of R&D | M-Exempt | 4,551 | $61.18 | $278K |
| 2026-09-15 | CAGNONI PABLO J | officer: President, Global Head of R&D | M-Exempt | 9,233 | $71.93 | $664K |
| 2026-08-25 | Basi Ramitpal K | officer: EVP, Human Resources | F-InKind | 504 | $129.72 | $65K |
| 2026-08-19 | CAGNONI PABLO J | officer: President, Global Head of R&D | SELL | 10,801 | $125.56 | $1.4M |
| 2026-08-12 | CAGNONI PABLO J | officer: President, Global Head of R&D | SELL | 10,803 | $120.04 | $1.3M |
| 2026-08-05 | CAGNONI PABLO J | officer: President, Global Head of R&D | SELL | 10,640 | $122.69 | $1.3M |
| 2026-08-05 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 2,207 | $106.47 | $235K |
| 2026-08-05 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | SELL | 2,207 | $123.99 | $274K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | SELL | 4,695 | $119.39 | $561K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | SELL | 14,661 | $119.46 | $1.8M |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 85 | $106.47 | $9K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 2,918 | $61.18 | $179K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 2,709 | $61.76 | $167K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 3,023 | $83.20 | $252K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 2,864 | $77.67 | $222K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 2,623 | $83.58 | $219K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | M-Exempt | 2,293 | $90.56 | $208K |
| 2026-07-31 | CAGNONI PABLO J | officer: President, Global Head of R&D | SELL | 15,888 | $119.70 | $1.9M |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | SELL | 2,187 | $119.47 | $261K |
| 2026-07-31 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | SELL | 6,171 | $119.43 | $737K |